about
Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanismMicroRNA-29b Contributes to Collagens Imbalance in Human Osteoarthritic and Dedifferentiated Articular Chondrocytes.Fenofibrate vs pioglitazone: Comparative study of the anti-arthritic potencies of PPAR-alpha and PPAR-gamma agonists in rat adjuvant-induced arthritis.Label-free relative quantification applied to LC-MALDI acquisition for rapid analysis of chondrocyte secretion modulation.Cytokines profiling by multiplex analysis in experimental arthritis: which pathophysiological relevance for articular versus systemic mediators?Inorganic pyrophosphate generation by transforming growth factor-beta-1 is mainly dependent on ANK induction by Ras/Raf-1/extracellular signal-regulated kinase pathways in chondrocytes.Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis.Review article: moving towards common therapeutic goals in Crohn's disease and rheumatoid arthritis.Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells.Management of patients with inflammatory bowel disease and spondyloarthritis.Experimental colitis delays and reduces the severity of collagen-induced arthritis in mice.TREM-1 Inhibition Restores Impaired Autophagy Activity and Reduces Colitis in Mice.Oxidative stress-induced expression of HSP70 contributes to the inhibitory effect of 15d-PGJ2 on inducible prostaglandin pathway in chondrocytes.Association between adiponectin and cartilage degradation in human osteoarthritis.Eplerenone treatment alleviates the development of joint lesions in a new rat model of spontaneous metabolic-associated osteoarthritis.Gut microbiome in chronic rheumatic and inflammatory bowel diseases: Similarities and differences
P50
Q28568835-6006E30C-0706-402D-9440-4B1DB45F15C5Q33762372-79E3B432-5299-4733-9114-207B22BF7323Q35188166-577B1018-B40E-4487-840C-8569BFE730D0Q35479341-E297C09F-9D9A-42B2-A4E0-0272D3ACCF37Q36245722-349E4FBF-4F2C-4466-8B56-4CEDBAE75293Q36465483-6F66B275-3024-469A-9D85-76E02B5FA76AQ36641580-FDE0CAC3-DB30-4806-8999-AC5BBBF0CFC8Q38752119-13322E7B-284E-44EE-8B45-6FFCE4B7C8A9Q40049209-1BCEC2CE-4089-45DF-A606-549A0F1FE4FFQ40054186-575FFDCE-0319-4097-83CF-D5732C57FCB7Q41677436-F5C16FCF-39F7-4CF2-9E73-4E1C04A18D4CQ47725450-525A3236-0665-4883-A542-8FE617D795C1Q51064013-853FE4CD-58C6-4566-9BBB-DA6C3D526135Q51165838-DE13428F-0B55-4B25-9ED7-77AFE074CF98Q53310345-B1ABE493-E3D3-48F2-BF06-524CBE64FA90Q90992570-3AAC46E6-A532-4DE1-9621-DEEF1E2D0220
P50
description
researcher, ORCID id # 0000-0001-6619-5769
@en
wetenschapper
@nl
name
David Moulin
@ast
David Moulin
@en
David Moulin
@es
David Moulin
@nl
type
label
David Moulin
@ast
David Moulin
@en
David Moulin
@es
David Moulin
@nl
prefLabel
David Moulin
@ast
David Moulin
@en
David Moulin
@es
David Moulin
@nl
P106
P21
P31
P496
0000-0001-6619-5769